Sign inGet started

BVTI.OB

BIOVEST INTERNATIONAL INCCIK 704384 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14

AI insights for BVTI.OB PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for BVTI.OB
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
HIRSCHEL MARK DCHIEF SCIENCE OFFICER10$0$02013-07-09
Santos CarlosSr. VP of Prod Dev/Reg Affairs9$0$02013-07-09
Calder Douglas WVP Strategic Plan/Cap Markets9$0$02013-07-09
Bottjer Brian DCFO and Controller8$0$02013-07-09
OSMAN RONALD EDirector, 10% Owner18$0$02013-07-09
Sitilides JohnDirector11$0$02013-07-09
CHAPMAN CHRISTOPHER CDirector8$0$02013-07-09
Scott JeffreyDirector7$0$02013-07-09
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC10$0$02013-07-09
KING EDMUNDDirector3$0$02013-07-09
MANNINO RAPHAEL JDirector7$0$02013-07-09
PAPPAS PETER JDirector12$0$02013-07-09
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRMAN18$0$02013-07-09
ACCENTIA BIOPHARMACEUTICALS INC10% Owner11$0$02013-02-22

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Bottjer Brian DCFO and Controller J Other deriv2013-07-092013-08-2375,000— $00SEC↗
Bottjer Brian DCFO and Controller J Other deriv2013-07-092013-08-23150,000— $00SEC↗
Bottjer Brian DCFO and Controller J Other deriv2013-07-092013-08-23500,000— $00SEC↗
Bottjer Brian DCFO and Controller J Other deriv2013-07-092013-08-2345,000— $00SEC↗
Bottjer Brian DCFO and Controller J Other deriv2013-07-092013-08-23282,800— $00SEC↗
Bottjer Brian DCFO and Controller J Other deriv2013-07-092013-08-2344,872— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-23150,000— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-2320,000— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-2310,000— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-23250,000— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-23850,000— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-23494,900— $00SEC↗
Calder Douglas WFMR VP STRAT PLAN/CAP MARKET J Other deriv2013-07-092013-08-23386,048— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-2320,000— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-2320,000— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-2360,000— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-2360,000— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-23100,000— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-23200,000— $00SEC↗
CHAPMAN CHRISTOPHER CDirector J Other deriv2013-07-092013-08-23176,750— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-23919,100— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-231,251,869— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-23500,000— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-231,500,000— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-233,000,000— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-23250,000— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-23150,000— $00SEC↗
DUFFEY SAMUEL SFORMER CEO/PRESIDENT/GC J Other deriv2013-07-092013-08-23500,000— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-23850,000— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-2319,375— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-2333,558— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-23250,000— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-2333,540— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-23150,000— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-23424,200— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-23512,393— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other deriv2013-07-092013-08-2360,000— $00SEC↗
KING EDMUNDDirector J Other deriv2013-07-092013-08-23200,000— $00SEC↗
KING EDMUNDDirector J Other deriv2013-07-092013-08-23176,750— $00SEC↗
MANNINO RAPHAEL JDirector J Other deriv2013-07-092013-08-23102,500— $00SEC↗
MANNINO RAPHAEL JDirector J Other deriv2013-07-092013-08-23176,750— $00SEC↗
MANNINO RAPHAEL JDirector J Other deriv2013-07-092013-08-23200,000— $00SEC↗
MANNINO RAPHAEL JDirector J Other deriv2013-07-092013-08-2360,000— $00SEC↗
MANNINO RAPHAEL JDirector J Other deriv2013-07-092013-08-2375,000— $00SEC↗
MANNINO RAPHAEL JDirector J Other deriv2013-07-092013-08-2375,000— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-2360,000— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-23281,250— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-23414,545— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-23459,550— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-2340,000— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-2375,000— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-231,000,000— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-23125,000— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other deriv2013-07-092013-08-231,950,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-23840,909— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-23150,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-231,125,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-231,640,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-233,636,360— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-235,333,333— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-23160,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-2360,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-2360,000— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other deriv2013-07-092013-08-23176,750— $00SEC↗
PAPPAS PETER JDirector J Other deriv2013-07-092013-08-23200,000— $00SEC↗
PAPPAS PETER JDirector J Other deriv2013-07-092013-08-23176,750— $00SEC↗
PAPPAS PETER JDirector J Other deriv2013-07-092013-08-2360,000— $00SEC↗
PAPPAS PETER JDirector J Other deriv2013-07-092013-08-2360,000— $00SEC↗
PAPPAS PETER JDirector J Other deriv2013-07-092013-08-23100,000— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-23636,300— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-23200,000— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-23850,000— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-23200,000— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-2315,000— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-231,000— $00SEC↗
Santos CarlosCHIEF EXECUTIVE OFFICER J Other deriv2013-07-092013-08-23494,124— $00SEC↗
Scott JeffreyDirector J Other deriv2013-07-092013-08-23176,750— $00SEC↗
Scott JeffreyDirector J Other deriv2013-07-092013-08-23107,500— $00SEC↗
Scott JeffreyDirector J Other deriv2013-07-092013-08-23200,000— $00SEC↗
Scott JeffreyDirector J Other deriv2013-07-092013-08-23105,000— $00SEC↗
Scott JeffreyDirector J Other deriv2013-07-092013-08-23105,000— $00SEC↗
Scott JeffreyDirector J Other deriv2013-07-092013-08-2365,000— $00SEC↗
Sitilides JohnDirector J Other deriv2013-07-092013-08-2330,000— $00SEC↗
Sitilides JohnDirector J Other deriv2013-07-092013-08-2390,000— $00SEC↗
Sitilides JohnDirector J Other deriv2013-07-092013-08-2390,000— $00SEC↗
Sitilides JohnDirector J Other deriv2013-07-092013-08-23200,000— $00SEC↗
Sitilides JohnDirector J Other deriv2013-07-092013-08-23105,000— $00SEC↗
Sitilides JohnDirector J Other deriv2013-07-092013-08-23176,750— $00SEC↗
HIRSCHEL MARK DCHIEF SCIENCE OFFICER J Other2013-07-092013-08-2355,800— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other2013-07-092013-08-2318,306— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other2013-07-092013-08-2384,951— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other2013-07-092013-08-23111,610— $00SEC↗
ODONNELL FRANCIS E JRFORMER DIRECTOR/EXEC. CHAIRM J Other2013-07-092013-08-232,991— $00SEC↗
OSMAN RONALD EDirector, 10% Owner J Other2013-07-092013-08-238,680,000— $08,680,000SEC↗
OSMAN RONALD EDirector, 10% Owner J Other2013-07-092013-08-2318,428— $01,165,366SEC↗
OSMAN RONALD EDirector, 10% Owner J Other2013-07-092013-08-2317,360,000— $017,360,000SEC↗
PAPPAS PETER JDirector J Other2013-07-092013-08-23524,545— $00SEC↗
PAPPAS PETER JDirector J Other2013-07-092013-08-23968,000— $00SEC↗
Sitilides JohnDirector J Other2013-07-092013-08-2327,927— $00SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2013-02-222013-02-224,794,373$0.12 $575.3K80,962,482SEC↗
DUFFEY SAMUEL SCEO/PRESIDENT/GENERAL COUNSE A Award deriv2012-08-242012-09-141,251,869— $01,251,869SEC↗
Santos CarlosSr. VP of Prod Dev/Reg Affai A Award deriv2012-08-242012-09-14494,124— $0494,124SEC↗
Calder Douglas WVP Strategic Plan/Cap Market A Award deriv2012-08-242012-09-14386,048— $0386,048SEC↗
Bottjer Brian DActing Chief Financial Offic A Award deriv2012-08-242012-09-1444,872— $044,872SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-08-072012-08-31400,000$0.75 $300.0K85,881,349SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-08-072012-08-31124,494$0.39 $48.6K85,756,855SEC↗
ODONNELL FRANCIS E JREXECUTIVE CHAIRMAN J Other deriv2012-06-152012-06-15125,000— $0414,545SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-05-312012-06-04400,000$0.75 $300.0K86,385,482SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-05-312012-06-04104,133$0.42 $43.7K86,281,349SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-04-272012-05-0179,929$0.51 $40.8K86,785,482SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-04-272012-05-01400,000$0.75 $300.0K86,865,411SEC↗
DUFFEY SAMUEL SCEO/PRESIDENT/GENERAL COUNSE A Award deriv2012-03-302012-04-03919,100— $0919,100SEC↗
ODONNELL FRANCIS E JREXECUTIVE CHAIRMAN A Award deriv2012-03-302012-04-03459,550— $0459,550SEC↗
Bottjer Brian DActing Chief Financial Offic A Award deriv2012-03-302012-04-03282,800— $0282,800SEC↗
Sitilides JohnDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
OSMAN RONALD EDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
KING EDMUNDDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
CHAPMAN CHRISTOPHER CDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
Scott JeffreyDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
PAPPAS PETER JDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
MANNINO RAPHAEL JDirector A Award deriv2012-03-302012-04-03176,750— $0176,750SEC↗
Santos CarlosSr. VP of Prod Dev/Reg Affai A Award deriv2012-03-302012-04-03636,300— $0636,300SEC↗
Calder Douglas WVP Strategic Plan/Cap Market A Award deriv2012-03-302012-04-03494,900— $0494,900SEC↗
PAPPAS PETER JDirector M Exercise deriv2012-03-212012-03-23245,455$0.32 $78.5K0SEC↗
PAPPAS PETER JDirector M Exercise deriv2012-03-212012-03-23109,090$0.32 $34.9K0SEC↗
PAPPAS PETER JDirector M Exercise2012-03-212012-03-23245,455$0.32 $78.5K1,492,545SEC↗
PAPPAS PETER JDirector M Exercise2012-03-212012-03-23109,090$0.32 $34.9K1,247,090SEC↗
Sitilides JohnDirector M Exercise deriv2012-03-162012-03-1913,636— $00SEC↗
Sitilides JohnDirector F Tax w/h2012-03-162012-03-197,273$0.60 $4.4K27,927SEC↗
Sitilides JohnDirector M Exercise2012-03-162012-03-1913,636$0.32 $4.4K35,200SEC↗
OSMAN RONALD EDirector G Gift2012-03-152012-03-191,165,366— $00SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-03-082012-03-0957,242$0.58 $33.2K87,265,411SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-03-082012-03-09400,000$0.75 $300.0K87,322,653SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-01-252012-03-09400,000$0.75 $300.0K87,811,152SEC↗
ACCENTIA BIOPHARMACEUTICALS IN10% Owner J Other2012-01-252012-03-0988,499$0.34 $30.1K87,722,653SEC↗
OSMAN RONALD EDirector M Exercise deriv2012-01-172012-01-19116,705— $00SEC↗
ODONNELL FRANCIS E JRExecutive Chairman M Exercise deriv2012-01-172012-01-19590,909— $00SEC↗
OSMAN RONALD EDirector F Tax w/h2012-01-172012-01-1998,277$0.38 $37.3K1,183,794SEC↗
OSMAN RONALD EDirector M Exercise2012-01-172012-01-19116,705$0.32 $37.3K1,282,071SEC↗
ODONNELL FRANCIS E JRExecutive Chairman M Exercise2012-01-172012-01-19590,909$0.32 $189.1K715,462SEC↗
ODONNELL FRANCIS E JRExecutive Chairman F Tax w/h2012-01-172012-01-19497,604$0.38 $189.1K217,858SEC↗